https://doi.org/10.18502/rmm.v5i4.3064
statistics
- 277 Abstract Views
- 142 PDF Views
- 0 HTML Views
- Cited by 7 articles
authors
-
Eizadi Mojtaba
No author data available.
-
Goodarzi Mohammad Taghi
No author data available.
-
Mirakhori Zahra
No author data available.
-
Amini Ashraf
No author data available.
Published Date
- Oct 10, 2018
Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
Abstract
Introduction: Many recent studies have focused on the possible role of corticosteroid inhalation in osteoporosis in asthmatic patients.
Aim: This study aimed to determine whether the indicators of bone formation or resorption are different between asthmatic patients and healthy subjects.
Materials and Methods: To achieve this outcome, 21 middle-aged patients with mild to moderate asthma treated with inhaled corticosteroid and the same number of healthy individuals matched for age (38 ± 6.5 years) were enrolled in this study by accessible sampling. All the subjects were non-trained and non-smokers. The serum levels of osteocalcin (OC), alkaline phosphatase (ALP), and cross-linked telopeptides of type I collagen (CTX) were measured to assess and compare bone formation and resorption between the two groups. An independent-sample t test was used to compare all variables between the patients with asthma and the healthy subjects.
Results: Significant differences in body weight and other anthropometrical markers were not observed between the two groups (p > 0.05). Serum osteocalcin level was borderline significantly lower in the asthmatic patients than in the healthy subjects (p = 0.051). The ALP level was significantly lower (p = 0.021) but the serum CTX levels were higher in the asthmatic patients than in the healthy subjects (p = 0.014).
Conclusion: On the basis of these findings, inhaled corticosteroid can affect bone turnover in asthmatic patients, although more research is needed to further explore any potential link between corticosteroids and osteoporosis.
References
74.
[2] Weatherall M. A meta-analysis of 25 hydroxyvitamin D in older people with a fracture of the proximal
femur. N Z Med J. 2000;113(1108):137-40.
[3] Jan JS, Wu WF. Acute effect of glucocorticoid treatment on serum osteocalcin levels in asthmatic
children. J Microbiol Immunol Infect. 2000;33(1):25-8.
[4] Bergmann P, Body JJ, Boonen S. Evidence-based guidelines for the use of biochemical markers of bone
turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus
document of the Belgian Bone Club. Int J Clin Pract. 2009;63(1):19-26.
[5] Seibel MJ. Biochemical markers of bone turnover, Part I: Biochemistry and variability. Clin Biochem
Rev. 2005;26(4):97-122.
[6] Moazami M, Sadat Jamali F. The effect of 6-months aerobic exercises on bone-specific alkaline phosphatase and parathyroid hormone in obese inactive woman. J Sport Biomotor Sci. 2014;10(2):71-8.
[7] Sucunza N, Barahona MJ, Resmini E, Fernández-Real JM, Ricart W, Farrerons J, et al. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J Clin Endocrinol Metab. 2009;94(10):3889-96.
[8] Emel’ianov AV, Shevelev SE, Amosov VI, Murzin BA, Shubin SA. Therapeutic potential of glucocorticoids inhalation in bronchial asthma. Ter Arkh. 1999;71(8):37-40.
[9] Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma. Allergol Immunopathol (Madr). 2001;29(1):22-7.
[10] Aljubran SA, Whelan GJ, Glaum MC, Lockey RF. Osteoporosis in the at-risk asthmatic. Allergy. 2014;69(11):1429-39.
[11] Barnes PJ. Inhaled corticosteroids. Pharmaceuticals 2010;3:514-40.
[12] Rhen T, Cidlowski JA. Anti-inflammatory action of glucocorticoids: new mechanisms for old drugs. N
Engl J Med. 2005;353(16):1711-23.
[13] Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet.
2009;373(9678):1905-17.
[14] Berger WE. Budesonide inhalation suspension for the treatment of asthma in infants and children.
Drugs. 2005;65(14):1973-89.
[15] Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North
Am. 2012;41(3):595-611.
[16] Georgiou KR, Hui SK, Xian CJ. Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. Am J Stem Cells. 2012;1(3):205-24.
[17] Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC. Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem. 2011;286(52):44326-35.
[18] Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010;11(6):517-31.
[19] Steinbeck K. Obesity and nutrition in adolescents. Adolesc Med State Art Rev. 2009;20(3):900-14.
[20] Maïmoun L, Simar D, Malatesta D, Caillaud C, Peruchon E, Couret I, et al. Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects. Br J Sports Med.
2005;39(8):497-502.
[21] Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of the deleterious effects on bone. J Clin Invest. 1998;102(2):274-82.
[22] Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res. 2006;21(3):466-76.
[23] Xia X, Kar R, Gluhak-Heinrich J, Yao W, Lane NE, Bonewald LF, et al. Glucocorticoid-induced autophagy
in osteocytes. J Bone Miner Res. 2010;25(11):2479-88.
[24] Alesci S, De Martino MU, Ilias I, Gold PW, Chrousos GP. Glucocorticoid-induced osteoporosis: from basic
mechanisms to clinical aspects. Neuroimmunomodulation. 2005;12(1):1-19.
[25] Monadi M, Javadian Y, Cheraghi M, Heidari B, Amiri M. Impact of treatment with inhaled corticosteroids
on bone mineral density of patients with asthma: related with age. Osteoporos Int. 2015;26(7):2013-8.